Page last updated: 2024-09-03

imatinib mesylate and Embolism, Pulmonary

imatinib mesylate has been researched along with Embolism, Pulmonary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lüscher, TF	1
Ghofrani, HA; Grimminger, F; Schermuly, RT; Seeger, W; Weissmann, N	1

Other Studies

2 other study(ies) available for imatinib mesylate and Embolism, Pulmonary

Article	Year
Pulmonary embolism and pulmonary hypertension: two issues often neglected in cardiology. European heart journal, 2015, Mar-07, Volume: 36, Issue:10 Topics: Acetazolamide; Antihypertensive Agents; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Oxygen; Peripheral Arterial Disease; Protein Kinase Inhibitors; Pulmonary Embolism; Randomized Controlled Trials as Topic; Thrombolytic Therapy	2015
[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension]. Deutsche medizinische Wochenschrift (1946), 2006, Apr-21, Volume: 131, Issue:16 Topics: Benzamides; Cell Division; Drug Therapy, Combination; Endothelin-1; Endothelium, Vascular; Fibromuscular Dysplasia; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyrimidines; Vasodilator Agents	2006

Article

Year

Pulmonary embolism and pulmonary hypertension: two issues often neglected in cardiology.

European heart journal, 2015, Mar-07, Volume: 36, Issue:10

Topics: Acetazolamide; Antihypertensive Agents; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Oxygen; Peripheral Arterial Disease; Protein Kinase Inhibitors; Pulmonary Embolism; Randomized Controlled Trials as Topic; Thrombolytic Therapy

2015

[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension].

Deutsche medizinische Wochenschrift (1946), 2006, Apr-21, Volume: 131, Issue:16

Topics: Benzamides; Cell Division; Drug Therapy, Combination; Endothelin-1; Endothelium, Vascular; Fibromuscular Dysplasia; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyrimidines; Vasodilator Agents

2006